Purpose: The aim of this study was to identify factors related to urinary incontinence in both sexes by analysing almost 2.500 individuals participating in a health screening project in the area of Vienna. Materials and Methods: An incontinence questionnaire (Bristol LUTS questionnaire) was included to health investigations. During this investigation (a) a medical history; (b) a physical investigation; (c) sociodemographic parameters including smoking, eating and drinking habits, and (d) urine and blood study including 14 parameters were obtained. The parameters collected during this health investigation were correlated to the presence of urinary incontinence to identify potential risk factors for urinary incontinence. Results: 1,262 women (49.7±13.6 years) and 1,236 men (48.6±13.0 years) were analyzed. In the female population, 26.3% reported on episodes of urinary incontinence during the past 4 weeks. Among other factors, age (correlation coefficient [r] = 0.22), body mass index (r = 0.20), urgency (r = 0.16), feeling of incomplete bladder emptying (r = 0.21), previous uro–gynecological surgery and fasting blood glucose correlated significantly to urinary incontinence. Five percent of men were incontinent, age (r = 0.12), urgency (r = 0.16), nocturia (r = 0.16), feeling of incomplete emptying (r = 0.16), reduced uroflow (r = 0.18) and previous prostatectomy (r = 0.11) correlated to the presence of urinary incontinence. In both sexes, smoking habits and the education level revealed no association. Conclusions: The high prevalence of urinary incontinence, its socioeconomic implications, the continuously ageing population and the fact that a number of potential risk factors, particularly in women, have been identified suggest that targeted prevention is a major task for the future.

Keywords:
Urinary incontinence, Prevalence, Men, Women, Risk
1.
Burigo KL, Locher JL, Zyczynski H, Hardin JM, Singh K: Urinary incontinence during pregnancy in a radically mixed sample: Characteristics and predisposing factors. Int Urogynecol J 1996;7:69–73.
2.
Brown JS, Seely DG, Fong J, Black DM, Ensrud KE, Grady D: Urinary incontinence in older women: Who is at risk? Obstet Gynecol 1996;87:715–721.
3.
Burigo KL, Matthews KA, Engel BT: Prevalence, incidence and correlates of urinary incontinence in healthy, middle–aged women. J Urol 1991;146:1255–1259.
4.
Hampel C, Wienhol D, Benken N, Eggersmann C, Thüroff JW: Prevalence and natural history of female incontinence. Eur Urol 1997;32(suppl 2):3–12.
5.
Nakayama H, Jorgensen HS, Pedersen PM, Raaschou HO, Olsen TS: Prevalence and risk factors of incontinence after stroke. Stroke 1997;28:58–61.
6.
Sustersic O, Kralj B: The influence of obesity, constitution and physical work on the phenomen of urinary incontinence in women. Int Urogynecol J 1998;9:140–144.
7.
McGrother C, Resnick M, Yalla SV, Kirschner–Hermanns R, Broseta E, Müller C, Welz–Barth A, Fischer GC, Mattelaer J, McGuire EJ: Epidemiology and etiology of urinary incontinence in the elderly. World J Urol 1998;16 (suppl 1):S3–S9.
8.
Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF: Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet Gynecol 1999;94:66–70.
9.
Steele AC, Kohli N, Mallipeddi P, Karram M: Pharmacologic causes of female incontinence. Int Urogynecol J 1999;10:106–110.
10.
Thüroff JW: Epidemiology of bladder control problems. Curr Opin Urol 1999;9:283–284.
11.
Parazzini F, Colli E, Origgi G, Surace M, Bianchi M, Benzi G, Artibani W: Risk factors for urinary incontinence in women. Eur Urol 2000;37:637–643.
12.
Bortolotti A, Bernardini B, Colli E, Di Benedetto P, Giocoli Nacci G, Landoni M, Lavezzari M, Pagliarulo A, Salvatore S, von Heland M, Parazzini F, Artibani W: Prevalence and risk factors for urinary incontinence in Italy. Eur Urol 2000;37:30–35.
13.
Kuh D, Cardozo L, Hardy R: Urinary incontinence in middle aged women: Childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health 1999;53:453–458.
14.
Temml C, Haidinger G, Schmidbauer J, Schatzl G, Madersbacher S: Urinary incontinence in both sexes: Prevalence rates and impact on quality of life and sexual life. Neurourol Urodynam 2000;19:259–271.
15.
Schatzl G, Temml C, Schmidbauer J, Dolezal B, Haidinger G, Madersbacher S: Cross–sectional study of nocturia in both sexes: Analysis of a voluntary health screening project. Urology 2000;56:71–75.
16.
Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank LV, Abrams P: The Bristol female lower urinary tract symptoms questionnaire: Development and psychometric testing. Br J Urol 1996;77:805–812.
17.
Swithinbank LV, Abrams P: A detailed description, by age, of lower urinary tract symptoms in a group of community–dwelling women. Br J Urol Int 2000;85(suppl 2):19–24.
18.
Handa VL, Harris TA, Ostergard DR: Protecting the pelvic floor: Obstetric management to prevent incontinence and pelvic organ prolapse. Obstet Gynecol 1996;88:470–478.
19.
Groutz A, Gordon D, Keidar R, Lessing JB, Wolman I, David MP, Chen B: Stress urinary incontinence: Prevalence among nulliparous compared with primiparous and multiparous premenopausal women. Neurourol Urodyn 1999;18:419–425.
20.
Foldspang A, Mommsen S, Lam GW, Elving L: Parity as a correlate of adult female urinary incontinence prevalence. J Epidemiol Comm Health 1992;46:595–600.
21.
Milsom I, Ekelund P, Molander U, Arvidsson L, Areskoug B: The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol 1993;149:1459–1462.
22.
Jolleys JV: Reported prevalence of urinary incontinence in women in a general practice. Br Med J 1988;296:1300–1302.
23.
Snooks SJ, Swash M, Henry MM, Setchell M: Risk factors in childbirth causing damage to the pelvic floor innervation. Int J Colorectal Dis 1986;1:20–24.
24.
Chiaffarino F, Chatenoud L, Dindelli M, Meschia M, Bouanguidi A, Amicarelli F, Surace M, Bertola E, Di Cintio E, Parazzini F: Reproductive factors, family history occupation and risk of urogenital prolapse. Eur J Obstet Gynecol 1999;82:63–67.
25.
Sultan AH, Kamm MA, Hudson CN: Pudendal nerve damage during labour: Prospective study before and after childbirth. Br J Obstet Gynecol 1994;101:22–28.
26.
Hording U, Pedersen KH, Sidenius K, Hedegaard L: Urinary incontinence in 45–year old women. Scand J Urol Nephrol 1986;20:183– 186.
27.
Mommsen S, Foldspang A, Elving L, Lam GW: Association between urinary incontinence in women and a previous history of surgery. Br J Urol 1993;72:30–37.
28.
Teasdale TA, Taffet GE, Luchi RJ, Adam E: Urinary incontinence in a community–residing elderly population. J Am Geriatr Soc 1988;36: 600–606.
29.
Harrison GL, Memel DS: Urinary incontinence: Its prevalence and its management in a health promotion clinic. Br J Gen Pract 1994; 44:149–152.
30.
Persson J, Wolner–Hanssen P, Rydhstroem H: Obstetric risk factors for stress urinary incontinence: a population based study. Obstet Gynecol 2000;96:440–445.
31.
Foldspang A, Mommsen S: Overweight and urinary incontinence in women. Ugeskr Laeger 1995;157:5848–5851.
32.
Nazir T, Kahn Z, Barber HR: Urinary incontinence. Clin Obstet Gynecol 1996;39:906–911.
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.